BioCentury
ARTICLE | Company News

Jasco Pharmaceuticals, Roswell Park Cancer Institute deal

June 10, 2013 7:00 AM UTC

Jasco and Roswell Park partnered to jointly conduct preclinical testing of Jasco's cancer compound JP-11646, including pharmacokinetic and pharmacodynamics analysis. The project will utilize Roswell ...